A PHASE 2, RANDOMIZED, HUMAN GROWTH HORMONE-CONTROLLED, MULTICENTER, BASKET STUDY OF VOSORITIDE IN CHILDREN WITH TURNER SYNDROME, SHORT STATURE HOMEOBOX-CONTAINING GENE DEFICIENCY, AND NOONAN SYNDROME WITH AN INADEQUATE RESPONSE TO HUMAN GROWTH HORMONE

Registry ID

111-211

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

BIOMARIN PHARMACEUTICAL INC

Start date

2026-06-15

Last update

2024-10-10

Conditions

• TURNER SYNDROME

Related clinical trials

• A STUDY COMPARING THE EFFECT AND SAFETY OF ONCE WEEKLY DOSING OF SOMAPACITAN WITH DAILY NORDITROPIN® AS WELL AS EVALUATING LONG-TERM SAFETY OF SOMAPACITAN IN A BASKET STUDY DESIGN IN CHILDREN WITH SHORT STATURE EITHER BORN SMALL FOR GESTATIONAL AGE OR WITH TURNER SYNDROME, NOONAN SYNDROME, OR IDIOPATHIC SHORT STATURE

View on source registry